Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II

NCT02560935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Stroke

Interventions

DRUG: Hydroxyurea (Moderate Dose)
DRUG: Hydroxyurea (Low Dose)

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]